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Abstract 
Background: Patients living with HIV/AIDS have complex medication regimens. Pharmacists within community pharmacy settings can 
have a role managing patients living with HIV/AIDS. Patients’ perspectives surrounding implementation about community 
pharmacist-based services is needed as limited information is available.  Objective: To identify medication-related needs of HIV-
infected patients who receive prescriptions from a community pharmacy. To determine patient perspectives and knowledge of 
community pharmacist-based services.  Methods: A qualitative research study involving in-depth, semi-structured interviews with 
patients was conducted. Inclusion criteria included: HIV positive men and women at least 18 years of age who receive care at a HIV 
clinic, currently take medication(s) and use a community pharmacy for all prescription fills. Patients were recruited from one urban 
and one rural health center. Patients answered questions about their perceptions and knowledge about the role and value of 
pharmacy services and completed a demographic survey. The recordings of the interviews were transcribed verbatim and were 
analyzed using principles of Grounded Theory. Results: Twenty-nine interviews were conducted: 15 participants from the urban site 
and 14 from the rural site. Five main themes emerged including: patients experience ongoing and varying medication-related needs; 
patients desire a pharmacist who is caring, knowledgeable and integrated with health care providers; patients expect ready access to 
drug therapy; patients value an individualized patient encounter, and patients need to be informed that a pharmacist-service exists. 
Conclusion: Patients with HIV value individualized and personal encounters with pharmacists at time intervals that are convenient for 
the patient. Patients felt that a one-on-one encounter with a pharmacist would be most valuable when initiating or modifying 
medication therapy. These patient perspectives can be useful for pharmacists and pharmacies interested in providing advanced care 
to patients with HIV. 
 
 
Introduction 
The care of patients with HIV has evolved as advancements in 
antiretroviral therapy have enabled patients to live longer. 
While these antiretroviral (ARV) regimens are highly effective, 
patients may be at increased risk for side effects, drug 
interactions, and medication nonadherence. Health problems 
associated with ARV use including insulin resistance or 
dyslipidemia can be problematic. Untreated psychiatric illness 
and active substance abuse, which have been shown to  
accelerate viral resistance to antiretroviral therapy (ART) are 
also common.
1,2,3
 
 
Corresponding author: Melissa Somma McGivney, PharmD, 
FCCP, School of Pharmacy, University of Pittsburgh, 721 Salk 
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Pharmacists in community pharmacy settings have 
demonstrated a positive impact through provision of 
medication therapy management for multiple chronic disease 
states and have been acknowledged for their evolving role in 
managing medication needs of patients.
4,5,6
  Pharmacists 
should have a significant role as part of the health care team 
through collaborative relationships with providers by 
addressing patients’ drug therapy problems and optimizing 
medication therapy within the patient-centered medical 
home and other innovative models demonstrating team-
based case.
7
 Traditionally, the role of pharmacists in HIV drug 
management has been recognized in inpatient and 
ambulatory clinic-based settings.
2,8
 Pharmacists have 
demonstrated the ability to work with patients to improve 
antiretroviral adherence, benefit clinical outcomes and 
reduce costs.
9
 However, few research studies have explored 
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the medication-related needs of patients with HIV in the 
community and how those needs could be met by a 
pharmacist. 
 
Pharmacists are ideally positioned to assist patients with 
comprehensive medication management (CMM). Patients 
with HIV can benefit from pharmacist-delivered patient care 
as pharmacists work with patients to develop therapy goals, 
address potential barriers to adherence, and provide 
education and support for patients on ART.
10,11 
 If 
implemented effectively, pharmacists caring for patients 
living with HIV may help lessen disparities in antiretroviral use 
and utilization of HIV services by underserved 
populations.
12,13 
 
In urban areas, overburdened HIV clinics may have limited 
resources to conduct and maintain retention and adherence 
activities.
14
 In rural settings, patients often travel long 
distances to receive HIV care at academic medical centers in 
urban areas, a barrier that has been identified repeatedly as 
an obstacle to adherence and retention to HIV care.
14
 As a 
means to provide consistent access to HIV care services, 
CMM provided for patients with HIV at their local community 
pharmacy could lead to improved adherence and reliable 
care as community pharmacies provide easily accessible 
locations.
15,16,17
 
 
Ten HIV/AIDS specialty pharmacies in California providing HIV 
medication therapy management (MTM) services have been 
studied.
18 
Medical claims of HIV-infected patients in pilot 
pharmacies offering HIV MTM services were compared to 
medical claims of HIV-infected patients in other Medi-Cal 
pharmacies that did not offer MTM services.   Clinically 
appropriate ART regimens and improved medication 
adherence for patients living with HIV/AIDS who received 
MTM were observed and sustained over a three-year time 
period.
19,20
  Provision of HIV MTM services resulted in greater 
drug-related expenditures than expected but were associated 
with lower costs for hospital admissions and emergency room 
visits. Overall costs associated with patient care were 
lowered suggesting the potential sustainability of HIV MTM 
services. Other studies have also demonstrated that patients 
who receive care at HIV-focused community pharmacies had 
improvements in medication adherence and persistence with 
ART.
21,22
 
 
While other research suggests how pharmacists can be 
involved in supporting ART adherence
23
, perceived 
medication-related needs and viewpoints about community 
pharmacist-based medication management services have not 
been explored from a patient perspective in this population. 
This study is intended to provide a valuable addition to 
current knowledge in order to guide the implementation of 
future interventions and development of programs that are 
aligned with the needs of this patient population.
24
 
 
Objectives 
The study objectives included: (1) Identify perceived 
medication-related needs of HIV-infected patients from 
urban and rural settings who receive prescriptions from a 
community pharmacy; (2) Explore patients’ perceived role of 
a pharmacist and value of CMM; and (3) Describe HIV-
infected patients’ preferences for participation in CMM.   
 
Methods 
Setting 
This study was conducted in collaboration with two health 
centers that deliver HIV care in one urban and one rural clinic 
in Pennsylvania (PA). The urban clinic is located in Pittsburgh, 
PA, and serves approximately 1200 patients in a calendar 
year. A clinical pharmacist provides patient care services at 
this site on a full-time basis. The rural clinic is located in 
Johnstown, PA and provides services to approximately 70 
patients in a calendar year. This site was structured to 
provide clinical pharmacist services for approximately 3 hours 
per month to patients at the time of study conduction. 
Participant Recruitment 
The patients included HIV positive men and women at least 
18 years of age who currently take prescription medication(s) 
and use a community pharmacy for all prescription fills. The 
clinics do not provide medications to patients. Flyers 
advertising the study were distributed at each location. 
Employees at the urban and rural clinic identified participants 
assisted with participant identification using study inclusion 
criteria and referred them to the study investigator for 
follow-up.  
 
Data Collection 
Individual, semi-structured interviews were conducted over a 
three-month period. All interviews were conducted by the 
principal investigator (Y.K) in a private room and continued 
until model saturation (when new data fails to elucidate 
original or unknown information) occurred.
25
 As outlined, 
interview questions (Table 1) were designed for the study. 
The principal investigator did not present personal views 
during data collection. An interview guide was used to 
provide consistency among interviews and probing questions 
were asked as needed when the interviewer needed more 
clarity of participants’ answers.  
 
All participants were offered a $15 gift card for their 
participation, and reimbursement was provided for parking 
and/or bus fares. Upon completion of the interview, 
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participants were asked to complete a demographic survey to 
collect the following data: age, sex, race/ethnicity, number of 
medications taken, pharmacy used to obtain medications, 
type of insurance, and number of years diagnosed with HIV, 
and confirmation of living in an urban or rural setting. 
Institutional Review Board approval was received from the 
University of Pittsburgh and the Conemaugh Health System 
before data collection occurred. 
 
Data Analysis 
The dialogue from the interviews was audio recorded and 
transcribed verbatim.  The principles of Grounded Theory 
were used to identify emerging themes from the interviews.
24
 
The purpose of grounded theory is to use emerging data to 
generate a theory, which provides increased understanding 
of a particular phenomenon and of the relationships between 
concepts that arise from the data. In grounded theory, data 
collection, coding and analysis occur immediately, 
concurrently, and throughout the conduct of the study. 
Interview transcripts were read and coded independently by 
two investigators (Y.K., E.B.). The investigators met to discuss 
potential codes and emergent themes that were apparent 
from the data.  The investigators documented thoughts and 
ideas about the data and those opinions were presented to a 
senior investigative panel (M.M., N.C., J.P.) to improve the 
trustworthiness of the data. A codebook was developed and 
ATLAS.ti qualitative data management software was used to 
label passages of text using the codebook. The transcripts 
were reviewed for any gaps, inconsistencies or new 
interpretation in analysis through the method of triangulation 
by the senior investigative panel. The coded text was grouped 
into categories to identify major themes and then the 
research team met to discuss the content of the coded 
interviews to collectively agree on themes.  This served as a 
quality check in order to improve the trustworthiness of the 
data.
26
 Survey data was summarized using descriptive 
statistics.  
 
Results 
Participant demographics  
Twenty-nine interviews were conducted: 15 patients from 
the urban site and 14 from the rural site.  Generally, there 
was an equal division of men and women among the patients 
interviewed. The urban population was predominantly 
African American while the rural population was balanced. 
The average age of patients was approximately 50 years in 
both groups. On average, patients were diagnosed with HIV 
14 years ago and were taking approximately nine 
medications. Patients visited a variety of pharmacy settings 
for their medications, and all patients had prescription drug 
benefits through Medicare, Medicaid, or were dual-eligible 
for both programs. (Table 2) 
Themes 
Thematic analysis of the interview transcripts identified five 
common themes. Similar findings were identified at both the 
rural and urban sites.  
 
Theme 1: Patients experience ongoing medication-related 
needs 
Patients in both geographic areas expressed that they have 
ongoing problems related to their medication (e.g. 
medication adherence, cost, access, drug interactions, 
adverse effects). Patients identified that they want help when 
starting or changing a medication and want to be able to 
choose when they need help and when they speak with a 
pharmacist. Patients also expressed that speaking with a 
pharmacist when first diagnosed with HIV would be an 
optimal time for patients to receive medication counseling 
from a pharmacist. 
 
Medication-related needs 
 Adverse effects: “They put me on Wellbutrin. And 
they’ll never get me to take it again because it 
ruined the ability to taste anything.” (Urban) 
 Adherence: “I’m on a lot of medications, and it’s 
hard for me to sometimes to keep track of them all.” 
(Urban) 
 Drug Interactions: “I am allergic to a few things. I’d 
want the pharmacist to make sure that my HIV 
medication won’t interact with the meds I’m already 
on for depression and everything else.” (Rural) 
 
Interaction with pharmacist 
 “I’m not sure if I would benefit [from pharmacy 
services], but I think that it may be good for people 
who are newly-diagnosed. They may not know as 
much about drug interactions and what over-the-
counter products they can take and which ones they 
can’t.” (Rural) 
 Another patient stated “It would have been nice if 
somebody would have the time in the beginning to 
kind of explain all this to me. The first time I took 
Atripla®, I woke up at 2:00 in the morning throwing 
up…I started doing the research on my own.” 
(Urban) 
 
Theme 2: Patients desire a pharmacist who is caring, 
integrated and knowledgeable  
Caring: Patients expressed wanting to speak with a 
pharmacist who is willing to develop a personal relationship 
with the patient and cares for them as an individual. Patients 
also feel that confidentiality should be a key component for 
every aspect of care.  
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 “I like the pharmacist because he takes time with 
me. I feel comfortable with him. He knows me 
personally. And I like that. Why wouldn’t you want 
that, someone to recognize you? Not just recognize 
you because you’re making them money with the 
pills. They know you personally, and I love that.” 
(Rural) 
 “Now it’s [HIV] more open, but there is still a stigma 
attached to it. And even though, it’s not as urgent as 
it was, people still know that there’s no cure. You 
just live a little longer. So I think it’s important that 
people’s confidentiality be protected.” (Urban) 
 “I was standing in line and the people at the 
pharmacy, I guess they must have said, “She’s the 
one with HIV,” cause they was all looking like this, 
trying to see my face, see who I was.” (Urban) 
 
Integrated: Patients also value a pharmacist who serves as a 
liaison between the patient and their doctor and is therefore 
able to acquire access to medical information as needed for 
the patient.  
 
 “The formularies change from time to time. So I’ll go 
in and find out suddenly something isn’t covered. In 
that event, it’s been relatively a routine thing where 
I say, “Okay I’m not going to pay that, so I'm not 
going to take the drugs. Please check with my 
pharmacist.” And my pharmacist, will check with the 
doctor and they’ll come up with a substitute.” 
(Urban) 
 “I’d rather be able to go to a place or be able to talk 
to a pharmacist or a pharmacy that knows my 
health, knows my medications, and is concerned 
about my well-being and making sure that any new 
meds that get added on doesn’t interfere with the 
other meds, especially the HIV meds. “ (Rural) 
 
Knowledgeable: Patients value interactions with pharmacists 
who can apply their knowledge specific to antiretroviral 
therapy to the individual. 
  
 “I look to the pharmacist as the expert…they’ve 
always been very accommodating with any question 
or concerns I’ve had.” (Rural) 
 “To meet with somebody who specializes in it, to 
talk to them about, I would feel more comfortable.” 
(Urban) 
 “They could tell me more about what the medicine is 
for, why I’m taking it, and the side effects I should 
have – if I have any, what they would be, and if, you 
know, I had any questions for them, they would be 
able to answer them for me.” (Rural) 
Theme 3: Patient expect ready access to drug therapy 
Patients expect a pharmacist to help them gain access to 
medications by coordinating with their physician to acquire a 
prescription. Pharmacists need to ensure that medications, 
especially their antiretroviral therapy, are in stock and 
available to patients when they need them.  
 
 “They’re very convenient here. They’ll call me and 
let me know if my prescription’s ready on my 
phone.” (Urban) 
 “I think [the pharmacist’s] responsibilities are to 
work with the patient to find the drugs in the most 
accessible way and the most affordable way.” 
(Urban) 
 “Every times that I go there, they get either my HIV 
meds or my heart meds. They always have them. I 
have never had a problem with [my pharmacy] 
having none of my meds, especially the HIV meds. 
The HIV meds were always there and I never had a 
problem.” (Rural) 
 
Theme 4: Patients value an individualized patient encounter 
Patients want to sit down with a pharmacist who understands 
their needs and who is able to apply individualized drug 
knowledge to their potential drug therapy problems.  
Availability for follow-up was also suggested when interacting 
with a pharmacist.  
 
 “Just a session to sit down with somebody such as 
yourself in an office like this and sit down and say, 
this is the medication you’re taking, this is what it’s 
for, this is how many times a day, and this is what it’s 
going to actually do.” (Urban) 
 “I think [this service] is an excellent one…you hear 
horror stories of people going to pharmacies and 
either picking up the wrong med or they might be 
prescribed something that interacts with other 
meds. It’s nice when you do have a pharmacy that 
does care about you and the medication you’re on.” 
(Rural) 
 
Theme 5: Patients need to be informed that the service exists 
if available in community pharmacies or HIV clinic settings. 
While six patients had interacted with a pharmacist in the 
clinic, not all patients were aware that a pharmacist was 
available or knew what to expect from a pharmacist. Overall, 
patients expressed that they felt it was important to have an 
increased awareness that these patient care services exist. 
Patients stated that they prefer to find out about these 
services through a group or organizational memberships, 
peers, doctor or health care center. Patient statements 
included the following: 
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 “I would want them to announce it through my 
support group case manger.” (Rural) 
 “I would want to have an intervention with the 
doctors to let them know, then the doctor could tell 
the patient.” (Urban) 
 
Discussion 
Prior to conducting this study, differences were expected in 
the needs and perspectives of patients in urban and rural 
settings based on the results of previous studies.
27-30
   
Previous data has demonstrated that HIV-infected patients in 
urban settings were more likely to have appointments with 
providers and use highly active antiretroviral therapy 
compared to patients in rural settings.
27 
Other data illustrated 
that 73.6% of HIV-infected patients living in rural areas 
received their HIV care in urban settings.
28
 This study 
suggests that patients’ opinions at both sites were similar and 
that patients generally want the same kinds of relationships 
and services from their pharmacist regardless of their setting.  
These attitudes are not specific to patients living with HIV as 
patients with other chronic diseases have identified skilled 
communication and a personal relationship with a pharmacist 
as valuable attributes.
31,32
  
 
Patients indicated that they want to interact with a 
pharmacist who is caring, knowledgeable and willing to 
develop a personal relationship with them.  Patients also 
value when pharmacists involved in their care approach them 
when initially diagnosed and check in periodically to find out 
how they are doing. Pharmacists should anticipate patients’ 
needs related to medications through automatic refill 
reminders or by contacting patients to determine if they need 
to refill their medication.  A pharmacist who serves as a 
liaison between the patient and their doctor and assists with 
obtaining antiretroviral therapy is important to this group of 
patients. While this phenomenon is not unique to HIV, what 
makes this study distinct is that patients are asking for a 
relationship with a pharmacist who understands their ART, 
side effects and drug interactions associated with the therapy 
and ultimately respects the relationship and protects patient 
confidentiality.  
 
Confidentiality was also expressed as a key component of 
patient care, which is consistent with other publications that 
have examined stigma associated with HIV.
33,34
 Some patients 
expressed their continual struggle when dealing with stigma 
associated with HIV and were concerned that their 
information would not remain confidential if the patient 
encounter did not occur in a private setting.  Patient 
confidentiality should be a central component of this service, 
and everyone involved in the care of this group of patients 
should be respectful of this need.   
 
This study demonstrates that over half of patients were not 
aware of existing pharmacist services within the HIV clinic or 
what a pharmacist could provide in these settings.  Patients 
should be made aware of pharmacist services that are 
available to help them. Further, by establishing relationships 
with other health care practitioners and support groups, 
pharmacists can increase awareness of what they are able to 
offer in these settings.  
 
While three-fourths of participants affirmed their interest in a 
one-on-one meeting with a pharmacist to discuss their 
medications in depth, patients expressed value in speaking 
with a pharmacist who had HIV training or knowledge specific 
to HIV pharmacotherapy. Existing opportunities are provided 
by organizations for pharmacists to gain focused knowledge 
about HIV pharmacotherapy.
35-38 
Community pharmacists 
could also establish mentoring relationships with HIV-trained 
pharmacists in clinics through the coordination of a statewide 
pharmacy network.  
 
Further, pharmacists in community pharmacy settings should 
develop processes for identifying patients who may benefit 
from HIV medication management programs and conduct 
initial and ongoing follow-up check-ins with patients to create 
a continuum of care. This will enable pharmacists to establish 
ongoing relationships with patients - relationships that are 
individualized to meet patients’ needs and mitigate and 
identify drug therapy problems. The results reinforce that 
patients value a relationship with a knowledgeable 
pharmacist that they can access at their convenience. 
Pharmacists must take strides to be informed about HIV 
disease and treatment of other comorbidities in patients 
living with HIV by engaging in training programs and with 
pharmacists who have expertise in HIV care.  
 
Pharmacists working in the community should outreach to 
pharmacists working in HIV clinic settings to develop 
collaborative relationships. Ultimately, this will enable 
pharmacists to become care managers especially for patients 
traveling a long distance to receive HIV care. The authors’ 
believe that outreach to state pharmacy organizations, public 
health agencies, and support groups can also help to bring 
awareness about these services. Pharmacists should 
anticipate additional opportunities to provide MTM due to 
the anticipated expansion of MTM services through the 
Patient Protection and Affordable Care Act.
39 
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Limitations  
One limitation to this study is patients’ opinions and 
perspectives may not be generalizable to other HIV 
populations as patients were recruited from two clinics in 
Pennsylvania. Individuals who were interviewed may be more 
likely to participate in HIV medication management services 
or recommend the service to other individuals who they 
believe would benefit.  These patients volunteered to be 
interviewed and thus may be taking a more active role in 
their healthcare.
40
 All interviews were conducted by a 
pharmacist, which may have influenced responses as 
participants may have tried to please the interviewer.
41 
This 
was minimized as the interviewer was trained to assure 
participant privacy and reaffirm that participants did not 
provide answers to please the interviewer.  
 
Conclusion 
This study suggests that patients with HIV are interested in 
individualized meetings with a pharmacist that are held at 
time intervals convenient for the patient and may be most 
useful when starting or modifying drug therapy. Patients 
value working with a pharmacists who is integrated with their 
health care providers and knowledge about their drug 
therapy. Further, confidentiality should be a key aspect of any 
interaction. These results may guide the implementation or 
enhancement of community pharmacist-based services for 
patients in urban and rural settings. Ultimately, these services 
can help to improve medication adherence, minimize drug 
therapy problems, and improve retention in care. 
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Table 1: Interview Guide 
Medication-related needs 
 Tell me about the medications that you take.  
 What kind of problems have you experienced with your medications now or in the past?  
 
Perceptions of the role of the pharmacist in their care 
 How does your pharmacist in the community take care of you?  
 How does the pharmacist in the ambulatory care clinic provide care for you?  
 Does the role of the ambulatory care pharmacist differ from that of your community pharmacist? 
IF: YES< HOW SO 
 
Perceived value of pharmacist services  
 What expectations would you have from a private one-on-one encounter with your community 
pharmacist?  
 What would you want to talk about during that meeting? 
 Are you concerned about confidentiality? If yes/no, tell me why you think that.  
 
Preference for implementation of pharmacist-based services 
 How would you want to find out about this service in a community pharmacy?  
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Table 2. Participant demographics in urban and rural settings 
 Urban (n = 15) Rural (n =14) 
Sex 
Male  9 (60%) 9 (64%) 
Female 6 (40%) 5 (36%) 
Race/Ethnicity 
African American 11 (73%) 5 (36%) 
Caucasian 4 (27%) 8 (57%) 
Latino/Hispanic 0 (0%) 1 (7%) 
Age (yrs) (mean ± SD) 51 ± 8 50 ± 11 
Highest education level completed 
Middle school 1 2 
Some high school 1 2 
High school diploma/GED 6 3 
Some college 3 3 
Associate degree 2 3 
Bachelor degree 1 0 
Graduate/Professional degree 1 1 
Number of years from diagnosis 
(mean ± SD) 
14.2  ± 8.0 13.9 ± 6.5 
Number of medications (mean ± 
SD) 
9.7 ± 5.4 8.1 ± 5.1 
Primary pharmacy used (may have selected more than one) 
Chain 4  8 
Independent 1  6 
Outpatient hospital pharmacy 11  0 
Mail Order 3  0 
Current health insurance status 
Medicare 2 (13.3%) 1 (7.1%) 
Medicaid 10 (66.7%) 8 (57.2%) 
Dual-eligible (Medicare & Medicaid) 3 (20.0%) 5 (35.7%) 
Private insurance 0 (0.0%) 0 (0.0%) 
 
